Abstract
A compound that targets the Wnt signaling pathway in cancer moves into therapeutic trials, 30 years after Wnt was discovered.
Original language | English (US) |
---|---|
Pages (from-to) | 922-923 |
Number of pages | 2 |
Journal | Science |
Volume | 337 |
Issue number | 6097 |
DOIs | |
State | Published - Aug 24 2012 |
ASJC Scopus subject areas
- General